A rare and deadly strain of hantavirus has triggered an international public health response after a cluster of infections broke out aboard the MV Hondius, a Dutch-flagged cruise ship. Health authorities are now investigating the unusual occurrence of human-to-human transmission, a characteristic rarely seen in hantavirus outbreaks, which typically require direct contact with infected rodents.
As of May 13, 2026, a total of 11 cases have been reported among passengers, resulting in three deaths—a case fatality ratio of 27%. The pathogen has been identified as the Andes virus (ANDV), a strain endemic to South America that causes Hantavirus cardiopulmonary syndrome (HCPS), a severe respiratory disease that can lead to rapid lung failure and hypotension.
The outbreak has spanned multiple continents, with cases confirmed or suspected in France, Spain, and the United States. While the World Health Organization (WHO) has assessed the risk to the general global population as low, the risk for those who were onboard the vessel is considered moderate due to the close-quarters environment of the ship.
The timeline of the outbreak began on May 2, 2026, when the United Kingdom notified the WHO of severe acute respiratory illness among passengers. Since then, the response has evolved into a complex international operation involving medical evacuations, specialized repatriation flights, and rigorous contact tracing across several countries.
The Path from South America to the High Seas
Epidemiologists are working under the hypothesis that the outbreak began with a single “spillover” event on land. Preliminary investigations into the travel history of the first infected passenger suggest the virus may have been acquired in the Southern Cone region of South America—specifically Argentina or Chile—possibly during bird-watching activities where the individual may have been exposed to rodent excreta.
Once the virus was introduced to the MV Hondius, the environment of the cruise ship likely facilitated its spread. Unlike most hantaviruses, the Andes virus has a documented, albeit limited, ability to spread between humans through close and prolonged contact. The ship’s shared indoor spaces and close living quarters created a high-risk setting for this secondary transmission.
Genetic sequencing has provided critical evidence for this theory. Preliminary analysis of the viral sequences shows a near-identical genetic match across different cases, with no more than one single nucleotide polymorphism (SNP) difference per individual. This strongly suggests the outbreak stemmed from a single initial infection rather than multiple separate exposures to rodents.
The following table summarizes the current case status as reported by health authorities:
| Case Category | Number of Cases | Outcome/Status |
|---|---|---|
| Laboratory-Confirmed | 8 | Includes 2 deaths |
| Probable | 2 | Includes 1 death |
| Inconclusive | 1 | Undergoing retesting (USA) |
| Total | 11 | 3 Deaths |
A Coordinated International Repatriation
The management of the MV Hondius cluster required a synchronized effort between the WHO, the European Centre for Disease Prevention and Control (ECDC), and national health ministries. The ship arrived in the Canary Islands, Spain, on May 10, where a massive disembarkation process began.
To prevent further community spread, passengers and crew were repatriated via specially arranged non-commercial flights. This operation was overseen by WHO experts and national authorities, including a visit to the Canary Islands by WHO Director-General Dr. Tedros Adhanom Ghebreyesus, who met with the Prime Minister of Spain on May 12 to coordinate the logistics.
Contact tracing is currently ongoing for all individuals who disembarked at various ports, including Saint Helena (UK) on April 24, Praia (Cabo Verde) on May 6, and Tenerife (Spain) on May 10 and 11. High-risk contacts—including household members and intimate partners—are being advised to undergo active monitoring or quarantine for 42 days following their last exposure.
As of May 11, the MV Hondius has departed the Canary Islands and is sailing toward the Netherlands. A skeleton crew of 25 remains on board, accompanied by two Dutch health workers tasked with continuous medical monitoring.
Medical Perspective: The Danger of Andes Virus
As a physician, it is important to distinguish the Andes virus from other hantaviruses. Most hantaviruses cause either hemorrhagic fever with renal syndrome (HFRS), common in Europe and Asia, or Hantavirus pulmonary syndrome (HPS) in the Americas. The Andes virus is particularly concerning because it is the only strain where human-to-human transmission has been consistently reported.
The clinical progression of ANDV is often aggressive. It typically begins with flu-like symptoms—fever, myalgia, and gastrointestinal distress—before rapidly progressing to severe respiratory distress and low blood pressure. Because the average age of the passengers on the MV Hondius was 65, the population was inherently more vulnerable to severe outcomes and comorbidities.
There is currently no licensed vaccine or specific antiviral treatment for Hantavirus pulmonary syndrome. Survival depends almost entirely on early supportive care. For critical cases, immediate transfer to an intensive care unit (ICU) for mechanical ventilation and, in some instances, extracorporeal membrane oxygenation (ECMO), is the only way to improve the chances of recovery.
For the general public, the risk remains negligible. The virus does not spread easily in typical social settings and requires the “prolonged close exposure” found in households or, in this specific instance, the confined environment of a ship.
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Please consult a healthcare professional for medical concerns or diagnosis.
Health authorities will continue to monitor the repatriated passengers and the remaining crew as the ship reaches the Netherlands. The next phase of the investigation will focus on the final genetic sequencing results to definitively map the transmission chain and confirm the original source of the spillover.
Do you have questions about travel health or zoonotic diseases? Share your thoughts in the comments or share this story with your network to help spread accurate health information.
